Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Physiological iron handling pathways refer to the integrated biological systems responsible for the absorption, transport, storage, and recycling of iron within the body (StatPearls, 2023). This system is primarily regulated by the hormone hepcidin, which controls the activity of ferroportin, the sole known cellular iron exporter (Blood, 2013). Iron is essential for vital processes such as oxygen transport via hemoglobin, DNA synthesis, and mitochondrial energy production, but its levels must be strictly maintained to prevent oxidative damage (NIH, 2023). Clinical disorders arise when these pathways are disrupted, leading to either iron deficiency or systemic iron overload, such as hereditary hemochromatosis (Nature Reviews Disease Primers, 2019). Pharmacological interventions include iron salts for replacement, chelating agents for detoxification, and emerging therapies that target specific regulatory proteins like hepcidin to manage complex anemias (Journal of Clinical Medicine, 2021).
Modulation of iron levels through supplementation, chelation, or regulation of the hepcidin-ferroportin axis (Journal of Clinical Medicine, 2021).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physiological iron handling pathways.